Skinvisible (SKVI) Return on Sales (2010 - 2026)

Skinvisible has disclosed Return on Sales across 17 years of filings, most recently posting 0.53% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.53%, up 3.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.53% (up 10.0% YoY), and the FY2025 annual result was 0.53%, up 10.0% from the prior year.
• Return on Sales came in at 0.53% for Q1 2026 at Skinvisible, down from 0.52% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q2 2022 to a low of 3.02% in Q1 2023.
• The 5-year median for Return on Sales is 0.56% (2023), against an average of 0.66%.
• Across the five-year window, Return on Sales slumped 296 bps in 2023 and jumped 244 bps in 2024, its largest moves.
• Skinvisible's Return on Sales stood at 0.82% in 2022, then gained by 26 bps to 0.61% in 2023, then decreased by 21 bps to 0.73% in 2024, then rose by 30 bps to 0.52% in 2025, then retreated by 3 bps to 0.53% in 2026.
• The last three Return on Sales figures came in at 0.53% (Q1 2026), 0.52% (Q4 2025), and 0.5% (Q3 2025), per Business Quant data.